View in EDS HTML Full Text PDF Full Text

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease.
Authors: Qiu, Yuqi1,2 (AUTHOR), Jacobs, Diane M.3,4 (AUTHOR) djacobs@ucsd.edu, Messer, Karen2,4 (AUTHOR), Salmon, David P.3,4 (AUTHOR), Wellington, Cheryl L.5,6 (AUTHOR), Stukas, Sophie5 (AUTHOR), Revta, Carolyn4 (AUTHOR), Brewer, James B.3,4 (AUTHOR), Léger, Gabriel C.3,4 (AUTHOR), Askew, Brianna4,7 (AUTHOR), Donahue, Lia7 (AUTHOR), Kaplita, Stephen7 (AUTHOR), Coric, Vladimir7 (AUTHOR), Qureshi, Irfan A.7 (AUTHOR), Feldman, Howard H.3,4 (AUTHOR), Obisesan, Thomas (AUTHOR), Smith, Amanda (AUTHOR), Heidebrink, Judith (AUTHOR), Mintzer, Jacobo (AUTHOR), Ala, Thomas (AUTHOR)
Source: Alzheimer's Research & Therapy. 5/2/2025, Vol. 17 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-025-01745-3